Response of Hepatitis C Genotype-4 Naïve Patients to 24 Weeks of Peg-Interferon-α2b/Ribavirin or Induction-Dose Interferon-α2b/Ribavirin/Amantadine: A Non-Randomized Controlled Study

Abdel Rahman El-Zayadi,Mohy El-Deen Attia,Eman Barakat,Hanaa M. Badran,Hassan Hamdy,Ahmed El-Tawil,Adham El-Nakeeb,Osaima Selim,Ahmed Saied

Response of Hepatitis C Genotype-4 Naïve Patients to 24 Weeks of Peg-Interferon-α2b/Ribavirin or Induction-Dose Interferon-α2b/Ribavirin/Amantadine: A Non-Randomized Controlled Study

2005

Abdel Rahman El-Zayadi
Mohy El-Deen Attia
Eman Barakat
Hanaa M. Badran
Hassan Hamdy
Ahmed El-Tawil
Adham El-Nakeeb
Osaima Selim
Ahmed Saied

Response of Hepatitis C Genotype-4 Naive Patients to 24 Weeks of Peg-Interferon-α2b/Ribavirin or Induction-Dose Interferon-α2b/Ribavirin/Amantadine: A Non-Randomized Controlled Study

Keywords:

Amantadine
PEG ratio
Randomized controlled trial
Gastroenterology
Hepatitis C
Cytokine
Interferon
Ribavirin
Virology
General surgery
Viral disease
Internal medicine
Medicine
Genotype
Antagonist

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations